NIH VideoCast - Phage Therapy to Combat Infections by Antibiotic-Resistant Bacteria

Skip Navigation

Phage Therapy to Combat Infections by Antibiotic-Resistant Bacteria

Loading... Loading video...

491 Views

Air date:	Wednesday, March 10, 2021, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 491 (264 Live, 227 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	01:02:58
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	WALS This is the annual Rolla E. Dyer Lecture, established in 1950 in honor this former NIH director, a noted authority on infectious diseases. The Dyer Lecture features internationally renowned researchers who have contributed substantially to medical as well as biological knowledge of infectious diseases. Dr. Turner is the Rachel Carson Professor of Ecology and Evolutionary Biology at Yale University. His laboratory studies the evolutionary genetics and genomics of microbes, especially the ability of viruses to adapt — or not — to changes in their biotic and abiotic environments. These studies concern environmental challenges faced by viruses at all levels of biological organization, including effects of changes in molecules, proteins, cells, populations, communities, and ecosystems. Increasing prevalence and severity of multi-drug-resistant bacterial infections require novel management strategies. One possible strategy is a renewed approach to 'phage therapy,' where these administered viruses not only kill the target bacteria, but also predictably select for phage resistance that reduces virulence and/or increases antibiotic sensitivity (evolutionary trade-offs). By utilizing virulence factors as receptor binding sites, the phages exert selection for bacteria to evolve phage resistance by modifying (or losing) the virulence factor, potentially reducing bacterial pathogenicity. We present examples of phages that utilize bacterial lipopolysaccharides, efflux-pump proteins, and pili as binding sites, to kill target bacteria while selecting for phage resistance that coincides with useful clinical traits such as antibiotic re-sensitization and reduced tissue inflammation. These in vitro observations are compared to phenotypic, genetic and metagenomics analyses of microbes isolated longitudinally from patient samples before, during and after emergency phage therapy treatments. Throughout, emphasis is placed on the ability to accurately predict how target bacterial pathogens will respond to phages administered either alone, sequentially, or in mixtures (cocktails). For more information go to https://oir.nih.gov/wals

Author:	Paul E. Turner, Ph.D., Rachel Carson Professor of Ecology and Evolutionary Biology, Yale University

CIT Live ID:	41443
Permanent link:	https://videocast.nih.gov/watch=41443

Related Videos...